Author archives: fvidal

• Taquicardias supraventriculares en infantes: epidemiología y manejo clínico

  May 11, 12 • 1939 Views • Arritmias en pediatria • fvidal • No Comments

    Supraventricular Tachycardia in Infants: Epidemiology and Clinical Management Maria Pia Calabrò1, Marco Cerrito2, Francesco Luzza2 and Giuseppe Oreto2,* Dipartimento di Scienze Pediatriche Mediche e Chirurgiche, Università di Messina and...

• Muerte subita y preexitacion ventricular (WPW), es necesario tratar los asintomaticos?

  May 11, 12 • 1786 Views • Arritmias en pediatria, Artículos • fvidal • No Comments

    Sudden Death and Ventricular Preexcitation: Is it Necessary to Treat the Asymptomatic Patients? Carlo Pappone *, Andrea Radinovic and Vincenzo Santinelli Department of Cardiology, Electrophysiology and Cardiac Pacing Unit, San Raffaele Scientific...

• Consenso antiarritmicos en pediatria: el problema de las drogas “off label”

  May 11, 12 • 2007 Views • Artículos • fvidal • No Comments

  Written Consent to Use the Drug in Children: The Problem of Off-Label Drugs                                             Gustavo Maid*, Marianna Guerchicoff, Mariano Falconi and Diego Perez de Arenaza...

• Ablacion por Radiofrecuencia en Pediatria

  May 11, 12 • 1834 Views • Arritmias en pediatria • fvidal • No Comments

    Transcatheter Ablation of Supraventricular Tachycardias in Pediatric Patients Antonella De Santis1,*, Giovanni Fazio2, Massimo Stefano Silvetti3 and Fabrizio Drago3 1 Department of Cardiology, San Camillo De Lellis Hospital, Rieti, Italy, 2Department...

• Videofluoroscopic Modified Barium Swallow Study for Premature Ventricular Complexes Associated Dysphagia

  Feb 8, 12 • 2467 Views • Arritmias Clinicas • fvidal • No Comments

  Caso clinico que demuestra que las extrasistoles ventriculares pueden provocar disfagia (observar los videos)            Videofluoroscopic Modified Barium Swallow Study for Premature Ventricular Complexes–Associated Dysphagia...

• Treatment of Unexplained Syncope, A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5

  Jan 11, 12 • 2026 Views • Arritmias Clinicas, Artículos • fvidal • No Comments

  Extraido de Circulation. 2012;125:31-36 Daniel Flammang, MD; Timothy R. Church, PhD; Luc De Roy, MD; Jean-Jacques Blanc, MD; Jean Leroy, MD; Georges H. Mairesse, MD; Akli Otmani, MD; Pierre J. Graux, MD; Robert Frank, MD; Philippe Purnode, MD; for the ATP...

• Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life

  Jan 11, 12 • 1517 Views • Artículos, Estimulación Cardíaca y Resincronización • fvidal • No Comments

  Extraido de J. Cardiovasc Electrophysiol, Vol. 22, pp. 1346-1350, December 2011 GUIDO H. VAN WELSENES, M.S.,∗ JOHANNES B. VAN REES, M.D.,∗ JOEP THIJSSEN, M.D.,SERGE A. TRINES, M.D., Ph.D., LIESELOT VAN ERVEN, M.D., Ph.D.,MARTIN J. SCHALIJ, M.D., Ph.D.,...

• Atrial Electrical and Structural Changes Associated with Longstanding Hypertension in Humans: Implications for the Substrate for Atrial Fibrillation

  Jan 11, 12 • 1371 Views • Artículos, Electrofisiología invasiva • fvidal • No Comments

    Extraido de J Cardiovasc Electrophysiol, Vol. 22, pp. 1317-1324, December 2011   Atrial Remodeling inHuman Hypertension.  Introduction: Hypertension (HT) is the most common modifiable risk factor for atrial fibrillation (AF), yet little is known...

• Patients With Diabetes, MI May Benefit From Omega-3 Fatty Acids (probable beneficio de Omega 3 en Diabeticos)

  Nov 24, 11 • 1601 Views • Artículos • fvidal • No Comments

  News Author: Larry Hand From Medscape Cardiology Education Clinical Context There is tremendous interest in the use of omega-3 fatty acids to prevent cardiovascular disease, but a previous study of the full cohort from the Alpha Omega Trial did not provide...

• Hypertrophic Cardiomyopathy Recommendations 2011 (Recomendaciones 2011 para Cardiopatía Hipertrófica)

  Nov 24, 11 • 1679 Views • Artículos • fvidal • No Comments

  News Author: Steve Stiles Hypertrophic cardiomyopathy (HCM) is a treatable disease compatible with a normal lifespan, and it is the most common inherited cardiac disease with an incidence of 1 in 500 worldwide. More than 1400 mutations account for...